Format

Send to

Choose Destination
Health Econ. 2010 Jan;19(1):88-100. doi: 10.1002/hec.1451.

Beneficiary price sensitivity in the Medicare prescription drug plan market.

Author information

1
Health Care Financing and Economics, VA Boston Healthcare System, Boston, MA 02130, USA. frakt@bu.edu

Abstract

The Medicare stand-alone prescription drug plan (PDP) came into existence in 2006 as part of the Medicare prescription drug benefit. It is the most popular plan type among Medicare drug plans and large numbers of plans are available to all beneficiaries. In this article we present the first analysis of beneficiary price sensitivity in the PDP market. Our estimate of elasticity of enrollment with respect to premium, -1.45, is larger in magnitude than has been found in the Medicare HMO market. This high degree of beneficiary price sensitivity for PDPs is consistent with relatively low product differentiation, low fixed costs of entry in the PDP market, and the fact that, in contrast to changing HMOs, beneficiaries can select a PDP without disrupting doctor-patient relationships.

PMID:
19191252
DOI:
10.1002/hec.1451
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center